California Financial Statements From 2010 to 2026

CANOF Stock  USD 0.25  0.01  4.17%   
California Nanotechnologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing California Nanotechnologies' valuation are provided below:
California Nanotechnologies Corp does not presently have any fundamental signals for analysis.
Check California Nanotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among California Nanotechnologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . California financial statements analysis is a perfect complement when working with California Nanotechnologies Valuation or Volatility modules.
  
This module can also supplement various California Nanotechnologies Technical models . Check out the analysis of California Nanotechnologies Correlation against competitors.

California Nanotechnologies Corp Company Current Valuation Analysis

California Nanotechnologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current California Nanotechnologies Current Valuation

    
  3.75 M  
Most of California Nanotechnologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, California Nanotechnologies Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, California Nanotechnologies Corp has a Current Valuation of 3.75 M. This is 99.97% lower than that of the Basic Materials sector and 99.99% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 99.98% higher than that of the company.

California Nanotechnologies Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining California Nanotechnologies's current stock value. Our valuation model uses many indicators to compare California Nanotechnologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across California Nanotechnologies competition to find correlations between indicators driving California Nanotechnologies's intrinsic value. More Info.
California Nanotechnologies Corp is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers fabricating about  0.65  of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for California Nanotechnologies Corp is roughly  1.54 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the California Nanotechnologies' earnings, one of the primary drivers of an investment's value.

About California Nanotechnologies Financial Statements

California Nanotechnologies stakeholders use historical fundamental indicators, such as California Nanotechnologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although California Nanotechnologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in California Nanotechnologies' assets and liabilities are reflected in the revenues and expenses on California Nanotechnologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in California Nanotechnologies Corp. Please read more on our technical analysis and fundamental analysis pages.
California Nanotechnologies Corp. engages in the research, development, and production of nano-structured components and materials. It serves microchip fabrication, aerospace, sports and recreation, defense, automotive, medical, and the oil and gas industries. California Nanotechnologies operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in California Pink Sheet

California Nanotechnologies financial ratios help investors to determine whether California Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in California with respect to the benefits of owning California Nanotechnologies security.